Visiopharm

Visiopharm builds AI-driven precision pathology software for research and diagnostics. The company provides image analysis tools that combine software applications with deep learning capabilities to help users analyze tissue images for applications such as spatial biology, biomarker assessment, and staining consistency. Their product offerings include tools like Discovery for training AI deep learning applications, Phenoplex for spatial biology workflows, and CE-IVD certified applications for diagnostic decision support in breast, lung, and prostate cancers.

The platform serves researchers, research scientists, and pathologists developing next-generation therapies or matching therapies with patients. The software integrates into various IMS and LIMS workflows and includes an APP Center with over 130 modular image analysis units designed to address specific tissue, stain, and modality types.